Kathy K Byrd1, Nasima M Camp2, Kashif Iqbal1, Paul J Weidle1. 1. Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. 2. Department of Health, Research, Informatics, and Technology, ICF, Atlanta, GA.
Abstract
BACKGROUND: Data to Care (D2C) is a strategy for using health departments' HIV surveillance data (HIV viral load and CD4 laboratory reports) to identify and re-engage not-in-care persons with HIV. In the current D2C model, there is a delay in the identification of persons not in care due to the time interval between recommended monitoring tests (ie, every 3-6 months) and the subsequent reporting of these tests to the health department. METHODS: Pharmacy claims and fulfillment data can be used to identify persons with HIV who have stopped filling antiretroviral therapy and are at risk of falling out of care. Because most antiretrovirals (ARVs) are prescribed as a 30-day supply of medication, these data can be used to identify persons who are not filling their medications on a monthly basis. The use of pharmacy claims data to identify persons not filling ARV prescriptions is an example of how "big data" can be used to conduct a modified D2C model. RESULTS: Although a D2C strategy using pharmacy data has not been broadly implemented, a few health departments are implementing demonstration projects using this strategy. As the projects progress, processes and outcomes can be evaluated. CONCLUSIONS: Tracking ARV refill data can be a more real-time indicator of poor adherence and can help identify HIV-infected persons at risk of falling out of HIV medical care.
BACKGROUND: Data to Care (D2C) is a strategy for using health departments' HIV surveillance data (HIV viral load and CD4 laboratory reports) to identify and re-engage not-in-care persons with HIV. In the current D2C model, there is a delay in the identification of persons not in care due to the time interval between recommended monitoring tests (ie, every 3-6 months) and the subsequent reporting of these tests to the health department. METHODS: Pharmacy claims and fulfillment data can be used to identify persons with HIV who have stopped filling antiretroviral therapy and are at risk of falling out of care. Because most antiretrovirals (ARVs) are prescribed as a 30-day supply of medication, these data can be used to identify persons who are not filling their medications on a monthly basis. The use of pharmacy claims data to identify persons not filling ARV prescriptions is an example of how "big data" can be used to conduct a modified D2C model. RESULTS: Although a D2C strategy using pharmacy data has not been broadly implemented, a few health departments are implementing demonstration projects using this strategy. As the projects progress, processes and outcomes can be evaluated. CONCLUSIONS: Tracking ARV refill data can be a more real-time indicator of poor adherence and can help identify HIV-infectedpersons at risk of falling out of HIV medical care.
Authors: Stephen F Derose; Kelley Green; Elizabeth Marrett; Kaan Tunceli; T Craig Cheetham; Vicki Y Chiu; Teresa N Harrison; Kristi Reynolds; Southida S Vansomphone; Ronald D Scott Journal: JAMA Intern Med Date: 2013-01-14 Impact factor: 21.873
Authors: Susan M Abughosh; Xin Wang; Omar Serna; Chris Henges; Santhi Masilamani; Ekere James Essien; Nancy Chung; Marc Fleming Journal: J Manag Care Spec Pharm Date: 2016-01
Authors: Lytt I Gardner; Gary Marks; Jason A Craw; Tracey E Wilson; Mari-Lynn Drainoni; Richard D Moore; Michael J Mugavero; Allan E Rodriguez; Lucy A Bradley-Springer; Susan Holman; Jeanne C Keruly; Meg Sullivan; Paul R Skolnik; Faye Malitz; Lisa R Metsch; James L Raper; Thomas P Giordano Journal: Clin Infect Dis Date: 2012-07-24 Impact factor: 9.079
Authors: M Meresse; L March; C Kouanfack; R-C Bonono; S Boyer; G Laborde-Balen; A Aghokeng; M Suzan-Monti; E Delaporte; B Spire; M-P Carrieri; C Laurent Journal: HIV Med Date: 2014-03-03 Impact factor: 3.180
Authors: W Tinago; J A O'Halloran; R M O'Halloran; A Macken; J S Lambert; G J Sheehan; P W G Mallon Journal: HIV Med Date: 2013-11-12 Impact factor: 3.180
Authors: Awachana Jiamsakul; Stephen J Kerr; Oon Tek Ng; Man Po Lee; Romanee Chaiwarith; Evy Yunihastuti; Kinh Van Nguyen; Thuy Thanh Pham; Sasisopin Kiertiburanakul; Rossana Ditangco; Vonthanak Saphonn; Benedict L H Sim; Tuti Parwati Merati; Wingwai Wong; Pacharee Kantipong; Fujie Zhang; Jun Yong Choi; Sanjay Pujari; Adeeba Kamarulzaman; Shinichi Oka; Mahiran Mustafa; Winai Ratanasuwan; Boondarika Petersen; Matthew Law; Nagalingeswaran Kumarasamy Journal: Trop Med Int Health Date: 2016-03-29 Impact factor: 2.622
Authors: Jason A Craw; Lytt I Gardner; Gary Marks; Richard C Rapp; Jeff Bosshart; Wayne A Duffus; Amber Rossman; Susan L Coughlin; DeAnn Gruber; Lauretta A Safford; Jon Overton; Karla Schmitt Journal: J Acquir Immune Defic Syndr Date: 2008-04-15 Impact factor: 3.731
Authors: Lytt I Gardner; Thomas P Giordano; Gary Marks; Tracey E Wilson; Jason A Craw; Mari-Lynn Drainoni; Jeanne C Keruly; Allan E Rodriguez; Faye Malitz; Richard D Moore; Lucy A Bradley-Springer; Susan Holman; Charles E Rose; Sonali Girde; Meg Sullivan; Lisa R Metsch; Michael Saag; Michael J Mugavero Journal: Clin Infect Dis Date: 2014-05-15 Impact factor: 9.079